Ginkgo biloba leaf extract (EGb 761) enhances catalepsy induced by haloperidol and L-nitroarginine in mice

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 11, 2005, Pages 1649-1654

  Fontana, L ^a   Souza, A S ^b   Del Bel, E A ^b   de Oliveira, R M W ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Catalepsy; Extrapyramidal system; Ginkgo biloba; Herbal medicine; Neuroleptic interaction; Nitric oxide

Indexed keywords

GINKGO BILOBA EXTRACT; HALOPERIDOL; N(G) NITROARGININE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PLANT LEAF; PREDICTION; SINGLE DRUG DOSE;

ANIMALIA; GINKGO BILOBA; RODENTIA;

EID: 27944505989     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005001100012     Document Type: Article

References (19)

1. MacLennan KM, Darlington CL & Smith PF (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67: 235-257.
2. Chandrasekaran K, Mehrabian Z, Spinnewyn B et al. (2003). Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Pharmacopsychiatry, 36 (Suppl 1): 89-94.
3. Oyama Y, Chikahisa L, Ueha T et al. (1996). Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Research, 712: 349-352.
4. Sharma HS, Drieu K, Alm P et al. (2000). Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat. Acta Neurochirurgica, 76 (Suppl): 81-86.
5. West AR, Galloway MP & Grace AA (2000). Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms. Synapse, 44: 227-245.
6. Kriegsfeld LJ, Eliasson MJ, Demas GE et al. (1999). Nocturnal motor coordination deficits in neuronal nitric oxide synthase knockout mice. Neuroscience, 89: 311-315.
7. Sandi C, Venero C & Guaza C (1995). Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. European Journal of Pharmacology, 277: 89-97.
8. Del Bel EA & Guimarães FS (2000). Sub-chronic inhibition of nitric-oxide synthesis modifies haloperidol-induced catalepsy and the number of NADPH-diaphorase neurons in mice. Psychopharmacology, 147: 356-361.
9. Del Bel EA, Souza AS, Guimarães FS et al. (2002). Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology, 161: 32-37.
10. Sanberg PR, Bunsey MD, Giordano M et al. (1988). The catalepsy test: its ups and downs. Behavioral Neuroscience, 102: 748-759.
11. Chermat R, Brochet D, DeFeudis FV et al. (1997). Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl β-carboline-3-carboxylate on social behavior of the rat. Pharmacology, Biochemistry, and Behavior, 56: 333-339.
12. Brailowsky S & Montiel T (1997). Motor function in young and aged hemiplegic rats: effects of a Ginkgo biloba extract. Neurobiology of Aging, 18: 219-227.
13. Porsolt RD, Martin P, Lenegre A et al. (1990). Effects of an extract of Ginkgo biloba (EGB 761) on "learned helplessness" and other models of stress in rodents. Pharmacology, Biochemistry, and Behavior, 36: 963-971.
14. Rapin JR, Lamproglou I, Drieu K et al. (1994). Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task. General Pharmacology, 25: 1009-1016.
15. Amri H, Drieu K & Papadopoulos V (1997). Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo biloba extract EGb 761 and isolated ginkgolide. Endocrinology, 138: 5415-5426.
16. Zhang XY, Zhou DF, Su JM et al. (2001). The effect of extract of Ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. Journal of Clinical Psychopharmacology, 169: 85-88.
17. Pires JG, Silva SR & Futuro-Neto HA (1996). Effects of losartan on neuroleptic-induced catalepsy in mice. Brazilian Journal of Medical and Biological Research, 29: 1045-1047.
18. Wadenberg ML (1996). Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neuroscience and Biobehavioral Reviews, 20: 325-339.
19. Moo-Puc RE, Gongora-Alfaro JL, Alvarez-Cervera FJ et al. (2003). Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology, 45: 493-503.